APA (7th ed.) Citation

Denker, S., Bittner, A., Frick, M., Kase, J., Hoffmann, J., Trenker, C., . . . Savic, L. J. (2025). 477 | LONGITUDINAL MULTI‐OMICS INVESTIGATION IN IBRUTINIB‐BORTEZOMIB‐R‐CHOP‐TREATED DLBCL PATIENTS. Hematological oncology, 43, 1. https://doi.org/10.1002/hon.70096_477

Chicago Style (17th ed.) Citation

Denker, S., et al. "477 | LONGITUDINAL MULTI‐OMICS INVESTIGATION IN IBRUTINIB‐BORTEZOMIB‐R‐CHOP‐TREATED DLBCL PATIENTS." Hematological Oncology 43 (2025): 1. https://doi.org/10.1002/hon.70096_477.

MLA (9th ed.) Citation

Denker, S., et al. "477 | LONGITUDINAL MULTI‐OMICS INVESTIGATION IN IBRUTINIB‐BORTEZOMIB‐R‐CHOP‐TREATED DLBCL PATIENTS." Hematological Oncology, vol. 43, 2025, p. 1, https://doi.org/10.1002/hon.70096_477.